FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $439,541 | -86.1% | 43,562 | -69.2% | 0.04% | -86.2% |
Q3 2022 | $3,172,315 | -82.4% | 141,558 | -80.5% | 0.28% | -78.5% |
Q2 2022 | $18,004,801 | +1.8% | 726,586 | +59.3% | 1.28% | -5.7% |
Q1 2022 | $17,681,407 | +18.6% | 456,059 | +79.0% | 1.36% | +42.6% |
Q4 2021 | $14,907,763 | -3.6% | 254,790 | -2.3% | 0.95% | -11.3% |
Q3 2021 | $15,463,247 | -48.6% | 260,895 | -24.7% | 1.07% | -46.4% |
Q2 2021 | $30,059,456 | +13.3% | 346,347 | +7.6% | 2.00% | +0.5% |
Q1 2021 | $26,529,112 | -27.0% | 321,760 | -19.5% | 1.99% | -53.2% |
Q4 2020 | $36,326,444 | +69.9% | 399,499 | -25.3% | 4.26% | -10.3% |
Q3 2020 | $21,385,389 | +17.3% | 535,036 | +0.7% | 4.75% | +90.2% |
Q2 2020 | $18,227,462 | +168.7% | 531,258 | +73.9% | 2.50% | +48.1% |
Q1 2020 | $6,784,822 | -3.9% | 305,485 | -15.3% | 1.69% | +35.4% |
Q4 2019 | $7,058,038 | +223.1% | 360,656 | +156.4% | 1.25% | +83.8% |
Q3 2019 | $2,184,388 | -50.6% | 140,656 | -35.4% | 0.68% | -45.2% |
Q2 2019 | $4,422,477 | -28.1% | 217,856 | -37.8% | 1.24% | -31.0% |
Q1 2019 | $6,149,693 | +190.5% | 350,011 | +112.1% | 1.79% | +56.5% |
Q4 2018 | $2,116,950 | – | 165,000 | – | 1.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |